fig5

Bilirubin ameliorates metabolic dysregulation by targeting the HSP90β/SREBPs signaling axis to improve insulin resistance and mitigate ectopic lipid deposition

Figure 5. Bilirubin inhibits the SREBP activity in HFD-fed mice. (A) Liver protein lysates (pooled from 3 mice/group) were immunoblotted with target-specific antibodies; (B) SREBP-1 expression levels were normalized to GAPDH for quantitative analysis; (C and D) Hepatic RNA extracts underwent Q-PCR quantification using mouse GAPDH as an endogenous control, per established protocols. Error bars represent standard deviations. n = 3. *P < 0.05; **P < 0.01; ***P < 0.001 vs. HFD. SREBP: Sterol regulatory element-binding proteins; HFD: high-fat diet.

Metabolism and Target Organ Damage
ISSN 2769-6375 (Online)
Follow Us

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/